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Flavonoids have been investigated for possible inverse associations with various chronic degenerative diseases, but there are no
epidemiologic data concerning a possible association between several of the main flavonoid categories and breast cancer risk. We
have applied recently published data on the flavonoid content of several foods and beverages on dietary information collected in the
context of a large case–control study of 820 women with breast cancer and 1548 control women, conducted in Greece. We found
a strong, statistically significant inverse association of flavone intake with breast cancer. The odds ratio for an increment equal to one
standard deviation of daily flavone intake (i.e. 0.5mgday
1) was 0.87, with 95% confidence interval 0.77–0.97. The association
persisted after controlling for fruit and vegetable consumption, or for other flavonoid intake. This inverse association is compatible
with and may explain the reported inverse association of breast cancer with consumption of vegetables, particularly leafy vegetables.
After controlling for dietary confounding, there was no association of breast cancer risk with flavanones, flavan-3-ols, flavonols,
anthocyanidins or isoflavones.
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Flavonoids are naturally occurring substances in plants (Peterson
and Dwyer, 1998). For five categories of flavonoids, namely
flavones, flavonols, flavan-3-ols, flavanones and anthocyanidins,
food composition data have been recently published by the US
Department of Agriculture (US Department of Agriculture, 2003),
while for a sixth category, that of isoflavones, food composition
data have been available for some time (US Department of
Agriculture-Iowa State University, 2002). Flavones, such as
apigenin and luteolin, are present chiefly in grains, leafy vegetables
and herbs. Flavonols are present in many plant foods: they include
the glycosides of quercetin in fruits, leaves and vegetables;
kaempferol in many fruits and leafy vegetables; isorhamnetin in
onions and pears; and myricetin in berries, maize and tea. Flavan-
3-ols, specifically the catechines, are abundant in ripe fruits, leaves,
tea and chocolate. The major sources of the flavanone class in
foods are citrus fruits and juices. The anthocyanidins are most
abundant in fruits and less frequent in cereals and vegetables. The
isoflavones include the compounds daidzein and genistein and are
found mainly in soya and soya products (Peterson and Dwyer,
1998).
As several flavonoids have antioxidant properties, as well as
antimutagenic and antiproliferative properties in vitro (Kandas-
wami et al, 1992; Franke et al, 1998; Takahashi et al, 1998;
Le Marchand et al, 2000), these compounds have been investigated
for possible inverse associations with various chronic diseases,
including cardiovascular diseases and several forms of cancer.
Studies have suggested that flavonoid intake may be associated
with reduced risks of certain types of cancer (Stoner and Mukhtar,
1995; Barnes et al, 1996) and coronary heart disease (Hertog et al,
1995; Hollman et al, 1996). A special interest on breast cancer
stems from the fact that several flavonoids, particularly isofla-
vones, have also antioestrogenic effects (So et al, 1997; Papas,
1999). Some (Ingram et al 1997; Zheng et al, 1999; Murkies et al,
2000; Dai et al, 2002) but not all (den Tonkelaar et al, 2001) studies
have found that diets high in isoflavones are associated with
decreased breast cancer risk. All these studies have relied on
urinary excretion measurements, which can theoretically be
affected by disease status. We have found no published
epidemiologic data concerning a possible association between
intake of any of the indicated other categories of flavonoids and
breast cancer risk.
The objective of the present investigation was to ascertain
whether one or more of the studied flavonoid categories was
associated with breast cancer risk. For this purpose, we applied
recently published data on the flavonoid content of several
foods and beverages (US Department of Agriculture-Iowa State Received 3 June 2003; revised 23 July 2003; accepted 25 July 2003
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information collected in the context of a large case–control study
of breast cancer, conducted in Greece in the early 1990s. In that
study (Katsouyanni et al, 1994; Trichopoulou et al, 1995), no
association was found between intake of energy-generating
nutrients and breast cancer risk, but consumption of fruits and
vegetables was inversely associated with the risk.
SUBJECTS AND METHODS
This study relies on data from a case–control study on diet and
breast cancer risk undertaken in Athens, Greece, from 1989 to
1991. The study included 820 incident histologically confirmed
cases of breast cancer, hospitalised in four major hospitals in the
Greater Athens area, and 1548 control women, who were either
hospital visitors or orthopaedic patients. Cases and controls were
interviewed in the hospitals by trained interviewers. The interview
covered demographic and reproductive information, and included
a semiquantitative food frequency questionnaire. An expanded
version of this questionnaire has been subsequently validated
(Gnardellis et al, 1995). Details about the study, case eligibility and
control selection procedures, as well as results concerning food
groups and energy-generating nutrients in relation to breast cancer
risk have been previously reported (Katsouyanni et al, 1994;
Trichopoulou et al, 1995).
All subjects were asked to indicate the average frequency of
consumption per month, per week or per day, of 115 food items
or beverage categories, during a period of 1 year before onset
of the present disease or before the interview for visitor
controls. Frequencies were translated into quantities using
typical portions sizes for each food item or beverage category
(Katsouyanni et al, 1994) and quantities were converted into
average daily intakes of various categories of flavonoids. Food
and beverage contents of flavones, flavonols, flavan-3-ols, flava-
nones, anthocyanidines and isoflavones were obtained from the US
Department of Agriculture databases (US Department of Agricul-
ture-Iowa State University Database, 2002; US Department of
Agriculture, 2003).
The data were modelled through logistic regression (Breslow
and Day, 1980) using the SPSS statistical package (Statistical
Package for Social Sciences v. 11.5, Chicago, IL, USA). The
effects of several established demographic and reproductive risk
factors for breast cancer were evident in the present study
(Katsouyanni et al, 1994). Thus, a core model was used that
included age (in years, continuously), place of birth (urban vs
rural), body mass index (in kgm
2, continuously), parity (parous
vs nulliparous), age at first pregnancy (in years, continuously,
among parous women), age at menarche (in years, continuously),
menopausal status (post- vs premenopausal) and ethanol intake
(o1 glass per month vs X1 glass per month). Exogenous
oestrogens were infrequently used in Greece in the late 1980s, as
reflected also in our study sample; therefore, exogenous oestrogen
use was not controlled for in this analysis (Lipworth et al, 1995).
As intake of most food items, food groups and nutrients is
positively associated with total energy intake, the latter variable
was always adjusted for in the evaluation of the association
between flavonoid intake and breast cancer risk (Willett and
Stampfer, 1998). Breast cancer odds ratios (ORs) were expressed
per increments equal to 1s.d. each of the evaluated categories of
flavonoids.
RESULTS
Table 1 shows the basic demographic and reproductive character-
istics, as well as patterns of alcohol consumption of 820 women
with incident breast cancer and 1548 control women. These
data serve only descriptive purposes, because cases are older
than controls and the indicated variables are not mutually
adjusted for.
In Table 2, cases and controls are distributed by marginal case
and control-combined quintiles of total energy intake and food
groups that are known major sources of flavonoids in the diet.
Age-adjusted linear trends assessing the difference in the
distributions of the indicated food groups and energy intake
between cases and controls are also shown. Linear trends were
assessed through X, which is the square root of w
2 with one degree
of freedom, as suggested by Armitage (1955) and generalised over
several strata by Mantel (1963). Cases reported higher intakes of
cereals, starchy roots, pulses and total energy, and lower intakes of
vegetables and fruits. Since comparisons are neither energy nor
mutually adjusted among flavonoid categories, valid differences
cannot be drawn from these data.
In Table 3, cases and controls are distributed by the studied
categories of flavonoids in the diet. There is evidence that breast
cancer risk is inversely associated with flavone intake and less
strong evidence for inverse associations with flavan-3-ol and
flavonol intake. However, as in Table 2, the data in Table 3 are
neither energy nor mutually adjusted and the patterns are not
directly interpretable.
In Table 4, OR (and 95% confidence intervals) of breast cancer
for 1s.d. increase in the consumption of each of the examined
major categories of flavonoids are presented. For each of the six
categories of flavonoids, ORs derived from three different models
are shown. In model I, the OR is adjusted for the socio-
demographic, lifestyle and reproductive variables shown in
Table 1, as well as for energy intake. These OR estimates may be
confounded by the intake of other flavonoid categories or by other
compounds in vegetables and fruits that are inversely associated
with breast cancer risk in these data. In model II, the ORs are
adjusted for fruit and vegetable consumption, in addition to the
variables controlled for in model I. In model III, the ORs for each
category of flavonoids are adjusted mutually, as well as for the
variables included in model I. Thus, OR estimates from models II
and III are less subject to confounding by other compounds in
fruits and vegetables, and other flavonoids in the diet. It is
apparent that the OR for flavones is fairly robust and indicates a
statistically significant inverse association with breast cancer risk,
even after taking into account the potential confounding effect of
fruit, vegetable and other flavonoid intake. No such evidence exists
for any other category of flavonoids examined.
Table 1 Basic demographic, lifestyle and reproductive characteristics of
820 women with breast cancer and 1548 control women
a
Cases
b,c Controls
b,c
Age (years) 56.4 (0.43) 54.4 (0.32)
Place of birth
Urban 620 (75.7) 1106 (71.6)
Rural 199 (24.3) 439 (28.4)
Body mass index (kgm
2) 26.6 (1.02) 25.9 (0.75)
Parity
Parous 657 (80.2) 1164 (75.2)
Nonparous 162 (19.8) 384 (24.8)
Age at first birth (years) 26.4 (0.21) 25.9 (0.16)
Age at menarche (years) 12.9 (0.06) 13.1 (0.04)
Menopausal status
Postmenopausal 550 (67.1) 1041 (67.3)
Premenopausal 270 (32.9) 505 (32.7)
Alcohol consumption
X1 glass per month 591 (72.2) 1086 (70.2)
o1 glass per month 228 (27.8) 462 (29.8)
aAdapted from Katsouyanni et al (1994).
bNonadditivity is accounted for by a few
missing values.
cIn parentheses: standard errors for quantative variables; percentages
for categorical variables.
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We have found evidence that flavones are inversely related to
breast cancer risk. The inverse association of flavone intake with
breast cancer was only marginally affected when intake of fruits
and vegetables, or other flavonoids was accounted for. The inverse
association of flavones with breast cancer is not trivial, since it
implies a 13% reduction in breast cancer risk per 1s.d.
(0.5mgday
1) of increase in the intake of the respective
compounds. Inverse associations with breast cancer risk were also
found for flavonols, flavan-3-ols and anthocyanidins. These
associations were sharply attenuated and became nonsignificant,
Table 2 Distribution of 820 women with breast cancer and 1548 control women by marginal frequency of consumption of food group sources of
flavonoids
a
Quintile
b
1 (lowest) 2 3 4 5 (highest) X
c linear trend
Cereals
Cases 164 146 164 176 169 1.78
Controls 369 270 309 297 303
Quintile median (times per month) 33 39 66 97 138
Vegetables
Cases 190 174 153 162 140 2.58
Controls 293 301 309 315 330
Quintile median (times per month) 47 74 90 108 142
Starchy roots
Cases 244 263 188 124 — 1.42
Controls 448 545 348 207
Quintile median (times per month) 4 8 8 16
Pulses, nuts and seeds
Cases 184 180 136 134 185 2.55
Controls 391 336 290 244 287
Quintile median (times per month) 2 4 5 7 13
Fruits
Cases 168 180 171 155 145 1.63
Controls 308 295 302 318 324
Quintile median (times per month) 43 78 109 137 183
Energy Intake
Cases 150 167 164 159 176 2.03
Controls 322 305 309 313 296
Quintile median (kJday
1) 5693 6855 7793 8809 10583
aAdapted from Trichopoulou et al (1995).
bNonadditivity is accounted for by a few missing values.
cX values are age-adjusted and are interpretable as standard normal deviates.
Table 3 Distribution of 820 women with breast cancer and 1548 control women by marginal quintiles of flavonoid intake categories
Quintile
a
1 (lowest) 2 3 4 5 (highest) X
b linear trend
Flavanones
Cases 162 167 158 178 154 0.29
Controls 311 307 315 296 319
Quintile median (mgday
1) 9.1 20.3 33.5 44.4 67.1
Flavan-3-ols
Cases 169 174 170 158 140 2.10
Controls 300 295 300 311 329
Quintile median (mgday
1) 9.0 16.0 23.5 30.7 45.2
Flavonols
Cases 179 167 153 159 151 1.65
Controls 289 302 315 310 317
Quintile median (mgday
1) 9.7 15.9 19.4 24.1 30.6
Flavones
Cases 197 187 158 146 131 4.63
Controls 276 287 315 328 342
Quintile median (mgday
1) 0.3 0.3 0.4 0.7 1.1
Anthocyanidins
Cases 186 251 55 170 149 0.83
Controls 319 459 157 286 315
Quintile median (mgday
1) 5.1 12.0 20.9 40.7 81.4
Isoflavones
Cases 172 149 174 158 166 0.71
Controls 301 329 295 316 307
Quintile median (mgday
1) 0.01 0.2 0.2 0.3 0.8
aNonadditivity is accounted for by a few missing values.
bX values are age-adjusted and are interpretable as standard normal deviates.
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were controlled for. We found no evidence that flavanones had a
major effect on breast cancer risk and, for isoflavones, the
evidence, if any, was for a positive rather than inverse association.
Very few studies have examined flavonoids in relation to breast
cancer risk. No association between cancer, including breast
cancer, and total flavonoids was found in the combined analysis of
the 16 cohorts of the Seven Countries Study (Hertog et al, 1995).
An inverse association between urinary excretion of phyto-
oestrogens, including isoflavones, was found among Chinese
women in Shanghai (Zheng et al, 1999; Dai et al, 2002) and
Australian women (Ingram et al, 1997; Murkies et al, 2000), but no
such association was evident in a similar study in Netherlands (den
Tonkelaar et al, 2001). With respect to isoflavones, our data do not
support those reported from studies in China and Australia. There
are several possible explanations: intake of soya and soya products
has been, and still is, very limited in Greece; an inverse association
between isoflavones and breast cancer risk may not be captured
through a dietary intake study, but may be ascertained in studies
employing measurements of urinary excretion; or reduced urinary
excretion of isoflavones may be a consequence rather than cause of
breast cancer and the procedures associated with the diagnosis and
treatment of this disease. There are no comparable data in the
literature concerning flavone intake in relation to breast cancer
risk so, at this stage, our findings concerning these compounds
should be considered as hypothesis generating rather than as
documenting a genuine association.
As flavones are largely derived from grains and vegetables
(Peterson and Dwyer, 1998), and there is no evidence in the
literature that grains or cereals are inversely associated with breast
cancer risk (World Cancer Research Fund and American Institute
for Cancer Prevention, 1997), our findings point to leafy vegetables
and herbs as the food groups with potential beneficial properties
for breast cancer risk. A source of concern is that vegetables were
more strongly inversely associated with breast cancer risk in this
Greek study (Trichopoulou et al, 1995) than in other case–control
and particularly cohort investigations (World Cancer Research
Fund and American Institute for Cancer Prevention, 1997; Smith-
Warner et al, 2001; Lagiou et al, 2002). However, consumption of
vegetables and variability of consumption is higher in the Greek
population than in most other populations (Agudo et al, 2002) and
Greek food patterns are characterised by high consumption of wild
greens that are rich in flavones (Trichopoulou et al, 2001).
Strengths of this study are its relatively large study size, the use
of a validated food frequency questionnaire and the reliance on
generally sound food composition databases (US Department of
Agriculture-Iowa State University Database, 2002; US Department
of Agriculture, 2003). Limitations of the study are the lack of a
flavone-specific prior hypothesis, the emergence of findings after
undertaking multiple analyses and questions concerning the
applicability of US-based flavonoid food composition tables to
Greek foods. A generic limitation is that confounding by dietary
factors that have not been measured cannot be controlled for
(Davey Smith and Ebrahim, 2003).
Various categories of flavonoids have been reported to inhibit
breast cancer cell replication, oestrone sulphatase activity and
mammary gland tumorigenesis in experimental analyses (So et al,
1996; Huang et al, 1997; Kuntz et al, 1999). However, except with
respect to isoflavones, there is no sufficient evidence, experimental
or otherwise, linking particular flavonoid compounds or categories
to specific actions in the process of mammary carcinogenesis.
Consequently, the biological plausibility of an inverse association
between flavones and breast cancer risk can, at this stage, be
considered as no more than suggestive.
In conclusion, we have found evidence that intake of flavones –
but not intake of flavonols, flavan-3-ols, flavanones or anthocya-
nidins or isoflavones – may be inversely related to breast cancer
risk. This inverse association is compatible with and may explain
the reported inverse association of breast cancer with consumption
of vegetables.
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